Associated Papers
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c).
Fiskus W et al.
Blood Cancer Journal, 2022
35017466 (PubMed )
Supplement: 41408_2021_603_MOESM1_ESM.pdf
Select a paper to view details